Artikel
Zahl privater Zusatzkrankenversicherungen hat sich verdoppelt
Given the growing variety of expensive treatments and drugs, economic sustainability is a particular challenge for healthcare systems with universal insurance coverage. Patient co-payment regimes for prescription drugs are a proven means of cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A study of the effects of a regulatory reform on pharmaceutical demand and expenditures in Denmark shows how market-oriented regulation can lead to substantial savings for consumers and healthcare systems.
- Language
-
Deutsch
- Bibliographic citation
-
Journal: DIW Wochenbericht ; ISSN: 1860-8787 ; Volume: 81 ; Year: 2014 ; Issue: 14 ; Pages: 302-307 ; Berlin: Deutsches Institut für Wirtschaftsforschung (DIW)
- Classification
-
Wirtschaft
Health: Government Policy; Regulation; Public Health
Single Equation Models; Single Variables: Panel Data Models; Spatio-temporal Models
- Subject
-
pharmaceutical markets
regulation
co-payments
reference pricing
- Event
-
Geistige Schöpfung
- (who)
-
Grabka, Markus M.
- Event
-
Veröffentlichung
- (who)
-
Deutsches Institut für Wirtschaftsforschung (DIW)
- (where)
-
Berlin
- (when)
-
2014
- Handle
- Last update
-
10.03.2025, 11:41 AM CET
Data provider
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Artikel
Associated
- Grabka, Markus M.
- Deutsches Institut für Wirtschaftsforschung (DIW)
Time of origin
- 2014